The impact of medical malpractice reforms, especially caps on noneconomic damages, is of special interest to policymakers and physicians. This study uses data from North Carolina to examine how caps implemented in noncrisis periods affect malpractice premiums.
This report describes the Volkswagen "clean diesel" emission fraud litigation to illustrate the features of global mass litigation and the problems that arise in the resolution of these types of claims across transnational jurisdictions.
This RAND Corporation virtual event explored how those who believe that they have been injured by COVID-19 vaccines in the United States can seek compensation and how the two federal compensation systems for people harmed by vaccines differ.
More than 2,000 plaintiffs have joined the largest civil trial in U.S. history: National Prescription Opiate Litigation (MDL 2804). In this virtual symposium, experts discuss the opioid litigation and its effects on the future of mass litigation.
A RAND virtual event focused on (1) facilitating global distribution of coronavirus disease 2019 (COVID-19) vaccines and (2) preventing liability and compensation concerns from affecting the vaccine supply chain and public uptake of the vaccine.
Concern about potential COVID-19 vaccine side effects and their consequences may be contributing to Americans' reluctance to get vaccinated. Policymakers and the public should carefully consider what types and levels of compensation for any adverse effects of vaccination are truly fair and appropriate.
The existing automobile insurance system in the United States should be flexible enough to accommodate the introduction of autonomous vehicles. Some changes to the insurance model may be indicated as vehicles incorporate higher levels of automation, but it is too early to make radical changes.
This article explains a surprising effect of tort liability in the market for prescription drugs: punitive damages shift liability from doctors to drug companies, but not when physician malpractice liability is limited."
Vaccine development is only one part of the challenge in creating an immunization campaign to stop the pandemic. Once a safe and effective COVID-19 vaccine is ready, liability and compensation issues could affect its distribution and administration.
This article proceeds in three parts: discussions of the general goals and role of public health tort litigation, the demonstrated and potential value of opioid litigation to achieve public health goals, and a conclusion.
After human-made disasters, early assistance from potentially responsible parties can sometimes fill gaps that are not always addressed by NGOs and first responders. But is providing such assistance a good strategy in terms of reducing future litigation or improving public opinion?
Researchers at RAND have been working on the technology behind driverless vehicles for over 50 years. From 1968 to the present, studies have involved remote-controlled drones, military land vehicles, autonomous submarines, and the safety and liability issues of self-driving cars.
This report reviews various alternatives to relying exclusively on traditional civil litigation to assign responsibility for the human causes of a catastrophe and to determine the types of losses that a designated responsible party must reimburse.